Legal, evidence-based psychedelic treatments
Our focus
We are developing the infrastructure required for a regulated psychedelics industry.
Ketamine-assisted psychotherapy & other innovative therapies
Legal, medically supervised psychedelic experiences
Clinical research for psychedelic medicines
Our network
Novamind is growing a network of specialized psychedelic clinics and retreats
Treatment is provided by blending evidence-based principles with psychedelic medicines
We guide individuals through their entire healing journey, both at home and abroad
Our approach
Novamind enables safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites.
We provide ketamine-assisted psychotherapy and other novel treatments through our network of Cedar Psychiatry clinics and operate Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.
Through our retreat partners, we offer additional access to psychedelics in jurisdictions with established regulations for the use of these alternative medicines.
Our values
Novamind is committed to a values-oriented approach to business. We will use our platform as a force for good, acknowledging and supporting the interests of our stakeholders.
Increase access to treatment for marginalized groups
Develop and study novel mental health treatment modalities
Responsible management of psychedelics in healthcare
Collaborate with non-profits, academic and indigenous groups